JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

The Journal of Nuclear Medicine Vol. 16 No. 7 666-668
© 1975 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kojima, M.
Right arrow Articles by Ito, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kojima, M.
Right arrow Articles by Ito, T.

New Adrenal-Scanning Agent

Masaharu Kojima, Minoru Maeda, Hiroshi Ogawa, Kazuo Nitta and Takayuki Ito

Kyushu University, Fukuoka
Daiichi Radioisotope Laboratories, Ltd., Tokyo, Japan

Correspondence: For reprints contact: Masaharu Kojima, Faculty of Pharmaceutical Sciences, Kyushu University, Maedashi 3-chome 1-1, Higashi-ku, Fukuoka 812, Japan.

ABSTRACT

A new adrenal-specific compound, 6ß-iodomethyl-19-norcholest-5(10)-en-3ß-ol (NCL-6-I), which is derived from 19-iodocholesterol (CL-19-I), has been found. Tissue distribution studies have revealed that the rat adrenal gland accumulates ten times more NCL-6-131I than CL-19-131I. The advantage of NCL-6-131I as a possible adrenal-scanning agent is discussed.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1975 by the Society of Nuclear Medicine.